Filter by

  • Publication Year
  • Availability
  • Attachment
  • Collection Type
    See More
  • General Material Designation
    See More
  • Location
    See More
  • Language
Found 1 from your keywords: author="de Macedo JCC"
cover
Vildagliptin modulates the microbiota and induces an immunometabolic profile …
Comment Share
de Macedo JCC

Dipeptidyl peptidase 4 (DPP-4) inhibitors (DPP-4i) are widely used to treat Type 2 diabetes (T2D) and are known for their cardiovascular and renal safety profiles. Systematic reviews have also shown that DPP-4i are associated with reduced dementia risk via unknown mechanisms. To examine vildagliptin (DPP-4i) effects on the intestinal microbiota in T2D patients, plasma metabolomics were conducte…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-